These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25963224)

  • 1. The role of point-of-care tests in antibiotic stewardship for urinary tract infections in a resource-limited setting on the Thailand-Myanmar border.
    Chalmers L; Cross J; Chu CS; Phyo AP; Trip M; Ling C; Carrara V; Watthanaworawit W; Keereecharoen L; Hanboonkunupakarn B; Nosten F; McGready R
    Trop Med Int Health; 2015 Oct; 20(10):1281-9. PubMed ID: 25963224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of children with urinary tract infection and the utility of urine dipstick as a diagnostic tool.
    Ojha AR; Aryal UR
    J Nepal Health Res Counc; 2014; 12(28):151-5. PubMed ID: 26032050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to antibiotics uropathogens bacteria in Nouakchott - Mauritania].
    Hailaji NS; Ould Salem ML; Ghaber SM
    Prog Urol; 2016 May; 26(6):346-52. PubMed ID: 27211808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: understanding and guidelines for action.
    García-Tello A; Gimbernat H; Redondo C; Arana DM; Cacho J; Angulo JC
    Actas Urol Esp; 2014 Dec; 38(10):678-84. PubMed ID: 24984581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity and specificity of a urine leukocyte esterase dipstick test for the diagnosis of urinary tract infection in the outpatient clinic of Rajavithi Hospital.
    Laosu-angkoon S
    J Med Assoc Thai; 2013 Jul; 96(7):849-53. PubMed ID: 24319857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
    Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicians' interpretations of point of care urine culture versus laboratory culture results: analysis from the four-country POETIC trial of diagnosis of uncomplicated urinary tract infection in primary care.
    Hullegie S; Wootton M; Verheij TJM; Thomas-Jones E; Bates J; Hood K; Gal M; Francis NA; Little P; Moore M; Llor C; Pickles T; Gillespie D; Kirby N; Brugman C; Butler CC
    Fam Pract; 2017 Aug; 34(4):392-399. PubMed ID: 28334777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In house-development of a rapid immunochromatographic test for the detection of Escherichia coli in urine samples.
    Da Cunda P; Mónaco A; Moreno M; José Gonzalez M; Scavone P; Robino L
    Rev Argent Microbiol; 2024; 56(2):140-146. PubMed ID: 38071171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Ipekci T; Seyman D; Berk H; Celik O
    J Infect Chemother; 2014 Dec; 20(12):762-7. PubMed ID: 25179392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection.
    Tasbakan MI; Pullukcu H; Sipahi OR; Yamazhan T; Ulusoy S
    Int J Antimicrob Agents; 2012 Dec; 40(6):554-6. PubMed ID: 23063743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance: Microbiological profile of urinary tract infections in Mexico.
    Sierra-Díaz E; Hernández-Ríos CJ; Bravo-Cuellar A
    Cir Cir; 2019; 87(2):176-182. PubMed ID: 30768071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum β-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives].
    Yamamoto A; Yamasaki K
    Nihon Ronen Igakkai Zasshi; 2015; 52(2):153-61. PubMed ID: 25994987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness.
    Butler CC; Francis NA; Thomas-Jones E; Longo M; Wootton M; Llor C; Little P; Moore M; Bates J; Pickles T; Kirby N; Gillespie D; Rumsby K; Brugman C; Gal M; Hood K; Verheij T
    Br J Gen Pract; 2018 Apr; 68(669):e268-e278. PubMed ID: 29483078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study.
    Little P; Turner S; Rumsby K; Warner G; Moore M; Lowes JA; Smith H; Hawke C; Turner D; Leydon GM; Arscott A; Mullee M
    Health Technol Assess; 2009 Mar; 13(19):iii-iv, ix-xi, 1-73. PubMed ID: 19364448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
    Lepeule R; Leflon-Guibout V; Vanjak D; Zahar JR; Lafaurie M; Besson C; Lefort A;
    Med Mal Infect; 2014 Dec; 44(11-12):530-4. PubMed ID: 25311839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.